Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | +0.29% | +10.09% | -9.11% |
04-04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
04-04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Neutral |
Resistance | 3.590 | 4.640 | 7.400 |
Spread/Res. | -2.79% | -24.78% | -52.84% |
Spread/Supp. | +11.50% | +17.51% | +83.68% |
Support | 3.130 | 2.970 | 1.900 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ABOS Stock
- Charts Acumen Pharmaceuticals, Inc.